• ImaginAb, CPDC enter into an agreement biospectrumasia
    September 03, 2018
    Under the terms of the agreement, CPDC will manufacture and distribute Zr-89 IAB22M2C to ImaginAb's Phase II clinical trial sites, Investigator Initiated Trial sites and to sites involved in studies being conducted in collaboration and partnership with ph
PharmaSources Customer Service